Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Operating Expenses | 12,245 | 11,840 | 12,586 | 8,736 |
| Operating Income | -12,245 | -11,840 | -12,586 | -8,736 |
| Interest Expense | 0 | 85 | 51 | 278 |
| Other Income | 513 | 2,316 | 1,368 | 21 |
| Pre-tax Income | -11,732 | -9,609 | -11,269 | -8,993 |
| Income Tax | 51 | 197 | 220 | 10 |
| Net Income Continuous | -11,783 | -9,806 | -11,489 | -9,003 |
| Net Income | $-11,783 | $-9,806 | $-11,489 | $-9,003 |
| EPS Basic Total Ops | -0.59 | -0.50 | -0.89 | -1.11 |
| EPS Basic Continuous Ops | -0.59 | -0.50 | -0.89 | -1.11 |
| EPS Diluted Total Ops | -0.59 | -0.50 | -0.89 | -1.11 |
| EPS Diluted Continuous Ops | -0.59 | -0.50 | -0.89 | -1.11 |
| EBITDA(a) | $-11,292 | $-11,590 | $-12,539 | $-8,700 |